Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 10, 2012
The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS
Andrew K L Goey, Hilde Rosing, Irma Meijerman, et al.
Investigational New Drugs
|
May 4, 2004
In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug
Esther F A Brandon, Rolf W Sparidans, Irma Meijerman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 16, 2013
Milk thistle's active components silybin and isosilybin: novel inhibitors of PXR-mediated CYP3A4 induction
Kim D Mooiman, Roel F Maas-Bakker, Ed E Moret, et al.
European Journal of Clinical Pharmacology
|
March 29, 2006
Screening for polymorphisms in the PXR gene in a Dutch population
Tessa M Bosch, Maarten Deenen, Roelof Pruntel, et al.
Investigational New Drugs
|
December 28, 2005
In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis, Trabectidin), a novel marine anti-cancer drug
Esther F A Brandon, Rolf W Sparidans, Kees-Jan Guijt, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2004
Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status
Tom Schalekamp, Mirjam Oosterhof, Erik van Meegen, et al.
Toxicology Letters
|
March 16, 2011
3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition
Irene Antolino-Lobo, Jan Meulenbelt, Sandra M Nijmeijer, et al.
The Journal of Pharmacy and Pharmacology
|
April 16, 2014
The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity
Kim D Mooiman, Andrew K L Goey, Tomy J Huijbregts, et al.
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology
|
July 22, 2021
A novel undergraduate biomedical laboratory course concept in synergy with ongoing faculty research
Willemijn D Schot, Maria A Hegeman, Toine Ten Broeke, et al.
Clinical Pharmacokinetics
|
September 27, 2013
The effect of St John's wort on the pharmacokinetics of docetaxel
Andrew K L Goey, Irma Meijerman, Hilde Rosing, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 10, 2012
The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS
Andrew K L Goey, Hilde Rosing, Irma Meijerman, et al.
Investigational New Drugs
|
May 4, 2004
In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug
Esther F A Brandon, Rolf W Sparidans, Irma Meijerman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 16, 2013
Milk thistle's active components silybin and isosilybin: novel inhibitors of PXR-mediated CYP3A4 induction
Kim D Mooiman, Roel F Maas-Bakker, Ed E Moret, et al.
European Journal of Clinical Pharmacology
|
March 29, 2006
Screening for polymorphisms in the PXR gene in a Dutch population
Tessa M Bosch, Maarten Deenen, Roelof Pruntel, et al.
Investigational New Drugs
|
December 28, 2005
In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis, Trabectidin), a novel marine anti-cancer drug
Esther F A Brandon, Rolf W Sparidans, Kees-Jan Guijt, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2004
Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status
Tom Schalekamp, Mirjam Oosterhof, Erik van Meegen, et al.
Toxicology Letters
|
March 16, 2011
3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition
Irene Antolino-Lobo, Jan Meulenbelt, Sandra M Nijmeijer, et al.
The Journal of Pharmacy and Pharmacology
|
April 16, 2014
The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity
Kim D Mooiman, Andrew K L Goey, Tomy J Huijbregts, et al.
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology
|
July 22, 2021
A novel undergraduate biomedical laboratory course concept in synergy with ongoing faculty research
Willemijn D Schot, Maria A Hegeman, Toine Ten Broeke, et al.
Clinical Pharmacokinetics
|
September 27, 2013
The effect of St John's wort on the pharmacokinetics of docetaxel
Andrew K L Goey, Irma Meijerman, Hilde Rosing, et al.
Page
of 3